Solid-phase extraction based on hydrophilic interaction liquid chromatography with acetone as eluent for eliminating matrix effects in the analysis of biological fluids by LC-MS

[1]  P. Sandra,et al.  Determination of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in human plasma and animal tissues by solid phase extraction on silica and liquid chromatography-triple quadrupole mass spectrometry. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  A. Furey,et al.  The Application and Validation of HybridSPE-Precipitation Cartridge Technology for the Rapid Clean-up of Serum Matrices (from Phospholipids) for the Clinical Analysis of Serotonin, Dopamine and Melatonin , 2012, Chromatographia.

[3]  M D Luque de Castro,et al.  Comparison of sample preparation approaches for phospholipids profiling in human serum by liquid chromatography-tandem mass spectrometry. , 2012, Journal of chromatography. A.

[4]  R. Kremer,et al.  Development and optimization of simplified LC-MS/MS quantification of 25-hydroxyvitamin D using protein precipitation combined with on-line solid phase extraction (SPE). , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  H. T. Karnes,et al.  Determination of octreotide and assessment of matrix effects in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  M. Chao,et al.  Quantitative determination of urinary N3-methyladenine by isotope-dilution LC–MS/MS with automated solid-phase extraction , 2011 .

[7]  A. Cappiello,et al.  An overview of matrix effects in liquid chromatography-mass spectrometry. , 2011, Mass spectrometry reviews.

[8]  N. Ferreirós,et al.  Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Li Li,et al.  Development and validation of a LC-MS/MS method based on a new 96-well Hybrid-SPE™-precipitation technique for quantification of CYP450 substrates/metabolites in rat plasma , 2011, Analytical and bioanalytical chemistry.

[10]  H. Karnes,et al.  Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  A. Cappiello,et al.  MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY , 2010 .

[12]  Eric J Woolf,et al.  Determination of sitagliptinin human plasma using protein precipitation and tandem mass spectrometry. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  M. Eddleston,et al.  Simultaneous quantification of the organophosphorus pesticides dimethoate and omethoate in porcine plasma and urine by LC-ESI-MS/MS and flow-injection-ESI-MS/MS. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  J. Reinders,et al.  Development and application of an LC–MS/MS method for measuring the effect of (partial) agonists on cAMP accumulation in vitro , 2010, Journal of Neuroscience Methods.

[15]  Vincenzo Pucci,et al.  A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPE. , 2009, Journal of pharmaceutical and biomedical analysis.

[16]  I. Leito,et al.  Combating matrix effects in LC/ESI/MS: the extrapolative dilution approach. , 2009, Analytica chimica acta.

[17]  L. Ding,et al.  Determination of bencycloquidium bromide in human urine using weak cation-exchange solid-phase extraction and LC-ESI-MS: Method validation and application to kinetic study of urinary excretion. , 2009, Journal of pharmaceutical and biomedical analysis.

[18]  Y. Michotte,et al.  Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  C. E. Wujcik,et al.  Overcoming ionization effects through chromatography: a case study for the ESI-LC-MS/MS quantitation of a hydrophobic therapeutic agent in human serum using a stable-label internal standard. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  G. K. Jain,et al.  Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[21]  G. Stubbings,et al.  The development and validation of a multiclass liquid chromatography tandem mass spectrometry (LC-MS/MS) procedure for the determination of veterinary drug residues in animal tissue using a QuEChERS (QUick, Easy, CHeap, Effective, Rugged and Safe) approach. , 2009, Analytica chimica acta.

[22]  Omnia A. Ismaiel,et al.  Monitoring phospholipids for assessment of ion enhancement and ion suppression in ESI and APCI LC/MS/MS for chlorpheniramine in human plasma and the importance of multiple source matrix effect evaluations. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  R. N. Rao,et al.  LC-ESI-MS determination and pharmacokinetics of adrafinil in rats. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[24]  P. Solich,et al.  Liquid chromatographic-electrospray mass spectrometric determination (LC-ESI-MS) of phase II metabolites of flobufen in rat liver microsomes-Chiral discrimination. , 2008, Talanta.

[25]  M. Larsson,et al.  Determination of rifalazil in dog plasma by liquid-liquid extraction and LC-MS/MS: quality assessment by incurred sample analysis. , 2007, Journal of pharmaceutical and biomedical analysis.

[26]  Erin Chambers,et al.  Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  M. Bogusz,et al.  Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[28]  Angus Nedderman,et al.  Analytical strategies for identifying drug metabolites. , 2007, Mass spectrometry reviews.

[29]  Sherry Wang,et al.  Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.

[30]  M. Giera,et al.  Multiresidue analytical method using dispersive solid-phase extraction and gas chromatography/ion trap mass spectrometry to determine pharmaceuticals in whole blood. , 2006, Journal of chromatography. A.

[31]  W. Lambert,et al.  Tackling matrix effects during development of a liquid chromatographic-electrospray ionisation tandem mass spectrometric analysis of nine basic pharmaceuticals in aqueous environmental samples. , 2006, Journal of chromatography. A.

[32]  Serge Rudaz,et al.  Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. , 2004, Journal of chromatography. A.

[33]  C. Chin,et al.  A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine. , 2004, Journal of pharmaceutical and biomedical analysis.

[34]  W. Lambert,et al.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.

[35]  M. Williams,et al.  Development of a sensitive bioanalytical method for determination of PNU-83757 in rat, monkey and human plasma: from LC-UV to LC-MS/MS. , 2002, Journal of pharmaceutical and biomedical analysis.

[36]  K. Markides,et al.  Studies of signal suppression in liquid chromatography-electrospray ionization mass spectrometry using volatile ion-pairing reagents. , 2001, Journal of chromatography. A.

[37]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[38]  T. Olah,et al.  The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. , 1999, Rapid communications in mass spectrometry : RCM.

[39]  E. Woolf,et al.  Effect of the sample matrix on the determination of indinavir in human urine by HPLC with turbo ion spray tandem mass spectrometric detection. , 1998, Journal of pharmaceutical and biomedical analysis.

[40]  Stefan Fischer,et al.  Enhanced sensitivity for peptide mapping with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression due to trifluoroacetic acid-containing mobile phases. , 1995, Journal of chromatography. A.

[41]  P. Kebarle,et al.  Dependence of ion intensity in electrospray mass spectrometry on the concentration of the analytes in the electrosprayed solution , 1993 .

[42]  S. Chowdhury,et al.  Factors affecting electrospray ionization of effluents containing trifluoroacetic acid for high-performance liquid chromatography/mass spectrometry. , 1993, Analytical chemistry.

[43]  K. Lemr,et al.  Effects of ion-pairing reagents on the electrospray signal suppression of sulphonated dyes and intermediates. , 2004, Journal of mass spectrometry : JMS.

[44]  C. Enke,et al.  Practical implications of some recent studies in electrospray ionization fundamentals. , 2001, Mass spectrometry reviews.